Tech Company Financing Transactions
Granata Bio Funding Round
On 1/15/2025, Granata Bio secured $15 million in Series A funding from Amboy Street Ventures, CooperSurgical and private investors.
Transaction Overview
Company Name
Announced On
1/15/2025
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to support its efforts to progress its existing pipeline and explore new innovative assets in reproductive health.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
289 St. George Street 209
Duxbury, MA 02332
USA
Duxbury, MA 02332
USA
Phone
Undisclosed
Website
Email Address
Overview
We are a biopharma company focused on women's health and infertility. Founded in 2018, Granata Bio's model is to identify and in-license strategic products for development and commercialization in North America. Granata Bio's mission and focus is to create access for fertility patients by introducing new therapeutic solutions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Evan Sussman
Chief Financial Officer
David Paller
Co-Founder
Marc Chung
VP - Bus. Development
Sarah Faranda
Browse more venture capital transactions:
Prev: 1/15/2025: qbiq venture capital transaction
Next: 1/15/2025: Shippeo venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records on this site are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs